申请人:USV Pharmaceutical Corporation
公开号:US04287203A1
公开(公告)日:1981-09-01
Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decanydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronaphthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, and Y is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.
结构为##STR1##的降压化合物,其中:n是从0到2的整数,包括R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7独立地为氢、具有1至6个碳原子的烷基、具有2至6个碳原子的烯基、具有2至6个碳原子的炔基、具有3至16个碳原子的环烷基、苯基、苄基、甲苯基、萘基、苯乙基、茚基、四氢萘基、十氢萘基、吡啶基、喹啉基、吡咯啉基、吡咯基、吗啉基、硫代吗啉基、呋喃基、呋喃基、四氢呋喃基、苯并咪唑基、噻吩基、咪唑基或四氢吲啶基,且R.sub.1到R.sub.7基团为烷基时,该基团携带从羟基、烷氧基、氨基、羧基或羰基中选择的取代基,烷氧基和羰基中的烷基基团具有1至6个碳原子,或者R.sub.2与R.sub.3及它们连接的碳一起形成四氢萘基或苯基,当苯基R.sub.1和R.sub.4缺失时,或者R.sub.6和R.sub.7与R.sub.6连接的碳和R.sub.7连接的氮一起形成从吡咯基、噻唑啉、四氢异喹啉、硫代吗啉或2,2,5,5-四甲基噻唑啉中选择的杂环,Y为.dbd.O、.dbd.S、.dbd.NR.sub.1、.dbd.NOR.sub.1或.dbd.N--NH.sub.2,其中R.sub.1与上述定义相同。